LicciardiLab

[LicciardiLab @LicciardiLab]

A massive thanks to everyone involved including all study participants!
@LicciardiLab @NadiaMazarakis @ZhengQToh Rachel Higgins Claire von Mollendorf @MulhollandKim @darrens_ong @LienAnhHaDo1 @TsegiBatmunkh and everyone else
@MCRI_for_kids NCCD Mongolia

[LicciardiLab @LicciardiLab]

Pleased to see several research findings recently published from our @CEPIvaccines funded RCTs of COVID-19 booster vaccination in Australia (Melbourne) and Mongolia:

10.1016/j.jinf.2026.106727
10.1016/j.vaccine.2026.128574
10.3389/fimmu.2026.1789248
10.3389/fimmu.2026.1779435

[LicciardiLab @LicciardiLab]

These publications report on:
1. 12-month followup of our Melb RCT
2. Time-of-Day vaccine effect on immunogenicity
3. 24-month followup of our Mongolia RCT of fractional v standard mRNA dosing
4. 12-month followup of CMI response in Mongolian RCT
Important for booster strategies

[AAMRI @AAMRI_Aus]

Half the funding. Half the future.
The Medical Research Future Fund was meant to deliver $1B each year — only $650M is reaching researchers.
Join the call to release the full funds now.
https://t.co/ng6kySc679
#releasethefullmrff
@Mark_Butler_MP @JEChalmers

[Fiona Russell @Fiona_M_Russell]

How multidisciplinary scientists & policy makers can work together to translate new knowledge into policy using a learning health systems approach

Our 2nd Forum
On PCV Access and Sustainability hosted by our @nhmrc Centre for Research Excelkence

https://t.co/UNayhbZqh6

[UNICEF @UNICEF]

In 2024, nearly 38 million children under five were acutely malnourished across 26 nutrition crises.

“We cannot respond to empty stomachs with empty hands and turned backs.” - @antonioguterres

Learn more. ⬇In 2024, nearly 38 million children under five were acutely malnourished across 26 nutrition crises.

“We cannot respond to empty stomachs with empty hands and turned backs.” - @antonioguterres

Learn more. ⬇️

[Murdoch Children's Research Institute (MCRI) @MCRI_for_kids]

One dose of the human papillomavirus (HPV) #vaccine is just as effective in providing long-term immune protection against #cervicalcancer as a two or three dose schedule, a new #MCRI-led study finds. 👉 https://t.co/0M6RbxUEx7
@LicciardiLab @ZhengQToh @qChauQuang

[LicciardiLab @LicciardiLab]

@KllN349312 @MCRI_for_kids @CEPIvaccines Longitudinal analysis out to 12m post vaccination is ongoing, stay tuned.

[Murdoch Children's Research Institute (MCRI) @MCRI_for_kids]

MCRI's Dr Nadia Mazarakis said both vaccines produced similar T-cell responses (a key part of your immune system that protects you from harmful viruses). The findings could help inform ongoing #booster strategies.

[Murdoch Children's Research Institute (MCRI) @MCRI_for_kids]

A new MCRI study found that as a 4th dose, Moderna boosted more #antibodies than Novavax but also caused more side effects. However, both #vaccines activated the immune system in a similar way.
Read more ➡️ https://t.co/rcbvVcC9M1
@CEPIvaccines

[LicciardiLab @LicciardiLab]

Our latest research on single dose #HPV vaccination just published @NatureComms -supports one dose strategy using systems serology https://t.co/2yRst8dY62
Great team science @ZhengQToh @AmyWChung and our PhD student @qChauQuang and everyone else involved @MCRI_for_kids @UniMelb

[nature @Nature]

In an unprecedented move, research-grant reviews have been suspended indefinitely at the world’s largest public funder of biomedical research

https://t.co/rEmlD6lFgE

[The Lancet @TheLancet]

Respiratory syncytial virus (RSV) is a major cause of illness and death in infants and older adults.

A Review in @TheLancetInfDis discusses the different RSV vaccines available and emphasizes the need to ensure these vaccines reach the most vulnerable: https://t.co/y3MinjZOLi

[Fiona Russell @Fiona_M_Russell]

Our ⁦@nhmrc⁩ CRE developed a new collaboration with ⁦@SirirajMedicine⁩ Thailand

Our 2 vs 3 PCV dose noninferiority RCT using the more affordable ⁦⁦@SerumInstIndia⁩ has recruited 100 in 3w 🎉

⁦@LicciardiLab⁩
⁦@CSatzke⁩
⁦@MCRI_for_kids⁩

[Murdoch Children's Research Institute (MCRI) @MCRI_for_kids]

A new #MCRI led study has found that fewer doses of #pneumococcal vaccines were just as effective at providing sustained immunity among Vietnamese babies. @MenziesResearch @darrens_ong @LicciardiLab @ThanhPh32823293 @ZhengQToh @MulhollandKim
👉 https://t.co/8ORWy8i1dm

[LicciardiLab @LicciardiLab]

Our recent preprint by postdoc Nadia Mazarakis is out on evaluation of SARS-CoV-2 antibody responses in adults and children using a novel microsampling device https://t.co/4E4Af27Whq Great to have the collaboration with @trajanscimed @SynexaLS @MCRI_for_kids @ZhengQToh

[Murdoch Children's Research Institute (MCRI) @MCRI_for_kids]

The Melbourne Vaccine Education Centre is inviting healthcare professionals to join an upcoming clinical vaccinology update on RSV at @RCHMelbourne on June 21. | #MCRI #RSV #Vaccination #InfectiousDisease @MVECau

Register ➡️ https://t.co/7h9eshtApH

[James McMahon @j_h_mcmahon]

Now hiring to a project officer role for the PROPHECY study. Large MRFF funded clinical and scientific collaboration studying COVID vaccine responses in high risk populations.@PROPHEC19

https://t.co/yhYeGD7pOy

https://t.co/nGeUHiDbWL

[Murdoch Children's Research Institute (MCRI) @MCRI_for_kids]

MCRI's @DanielPellicci has been awarded a Viertel Senior Medical Research Fellowship. This #research could help reduce the severity of #Tuberculosis, #StrepA and #RSV - and pave the way for future #vaccines.
Read more👉https://t.co/HB9jGlefI3

[Daniel Griffin MD PhD @DanielGriffinMD]

Is the Novavax COVID Vaccine Better than mRNA Vaccines? What We Know So Far - Scientific American https://t.co/I2z76huE9b